KN Anderson, RB Schwab, ME Martinez - Breast cancer research and …, 2014 - Springer
Aside from age, sex, and family history, risk of developing breast cancer is largely linked to reproductive factors, which characterize exposure to sex hormones. Given that, molecular …
Background Associations between reproductive factors and breast cancer (BC) risk vary by molecular subtype (ie, luminal A, luminal B, HER2, and triple negative/basal-like [TNBC]). In …
JR Palmer, E Viscidi, MA Troester… - Journal of the …, 2014 - academic.oup.com
Abstract Background African American (AA) women have a disproportionately high incidence of estrogen receptor–negative (ER-) breast cancer, a subtype with a largely …
M Ellingjord-Dale, L Vos, S Tretli, S Hofvind… - Breast cancer …, 2017 - Springer
Background Breast cancer comprises several molecular subtypes with different prognoses and possibly different etiology. Reproductive and hormonal factors are associated with …
Multiple studies have found the neutrophil to lymphocyte ratio (NLR) to be associated with adverse breast cancer (BC) prognosis and survival. Very limited data exist on the role of …
M Abubakar, H Sung, D Bcr, J Guida, TS Tang… - Breast Cancer …, 2018 - Springer
Background Limited evidence, mostly from studies in Western populations, suggests that the prognostic effects of lifestyle-related risk factors may be molecular subtype-dependent. Here …
M Khalis, B Charbotel, V Chajès, S Rinaldi, A Moskal… - PloS one, 2018 - journals.plos.org
Background Breast cancer is the most common cancer in women worldwide. In the Moroccan context, the role of well-known reproductive factors in breast cancer remains …
AY Jung, TU Ahearn, S Behrens… - JNCI: Journal of the …, 2022 - academic.oup.com
Background Reproductive factors have been shown to be differentially associated with risk of estrogen receptor (ER)-positive and ER-negative breast cancer. However, their …
R Schwab, K Anic, A Hasenburg - Cancers, 2021 - mdpi.com
Simple Summary The co-occurrence of cancer and pregnancy is fortunately a rare event. It is a challenging situation for all involved parties, as the risks and benefits of oncological …